Mast Therapeutics, Inc. (MSTX)

[pray]

Really do not think MSTX is a "scam." as some would suggest. They have an excellent product line with great potential.

My concern is leadership .... period. This could be floating at $2.50-4.00 right now with a CEO bent on being a example of integrity and trust. Instead every chance he gets he will give options to himself, dilute, increase share structure or advance a public offering at shareholders expense.

GlycoMimetics recently received $20 Million Payment from Pfizer. I know Culley hated this because it pointed out what a weak CEO he is. Rachel K. King, the Chief Executive Officer of GlycoMimetics had taken pay-cuts and showed that women can do a far superior job than men as Culley who are only looking out for himself. Culley would do everyone a favor by staying off the golf course, being a apprentice or interim for Rachel K. King and seeing were self sacrifice will get you. Good luck and welcome to IHUB.